Global Vitreo Retinal Surgery Devices Pipeline Report 2022 Update: Formulate Significant Competitor Information, Analysis, and Insights to Improve R&D Strategies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Nov 7, 2022--

The "Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.

The report enables you to:

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Vitreo Retinal Surgery Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Scope

• Extensive coverage of the Vitreo Retinal Surgery Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Vitreo Retinal Surgery Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment/industry

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Products under Development

3.1 Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development

3.2 Vitreo Retinal Surgery Devices - Pipeline Products by Territory

3.3 Vitreo Retinal Surgery Devices - Pipeline Products by Regulatory Path

3.4 Vitreo Retinal Surgery Devices - Pipeline Products by Estimated Approval Date

3.5 Vitreo Retinal Surgery Devices - Ongoing Clinical Trials

4 Vitreo Retinal Surgery Devices - Pipeline Products under Development by Companies

4.1 Vitreo Retinal Surgery Devices Companies - Pipeline Products by Stage of Development

4.2 Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development

5 Vitreo Retinal Surgery Devices Companies and Product Overview

5.1 ABVC BioPharma Inc Company Overview

5.2 AcuSurgical Company Overview

5.3 Alcon Inc Company Overview

5.4 Bausch & Lomb Inc Company Overview

5.5 Beaver-Visitec International Inc Company Overview

5.6 Boston College Company Overview

5.7 Cambridge Polymer Group Inc Company Overview

5.8 Carnegie Mellon University Company Overview

5.9 Duke University Company Overview

5.10 Dutch Ophthalmic Research Center International BV Company Overview

5.11 Johns Hopkins University Company Overview

5.12 King's College London Company Overview

5.13 Medisse BV (Inactive) Company Overview

5.14 RetinaSense Company Overview

5.15 Synergetics USA, Inc. (Inactive) Company Overview

5.16 The Chinese University of Hong Kong Company Overview

5.17 University of Kansas Company Overview

5.18 University of Minnesota Company Overview

6 Vitreo Retinal Surgery Devices- Recent Developments

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/zd122m

Source: GlobalData

View source version on businesswire.com:https://www.businesswire.com/news/home/20221107005890/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: TECHNOLOGY HEALTH OPTICAL HEALTH TECHNOLOGY OTHER SCIENCE OTHER TECHNOLOGY MEDICAL DEVICES RESEARCH SURGERY SCIENCE CLINICAL TRIALS

SOURCE: Research and Markets

Copyright Business Wire 2022.